The approval from China's NMPA allows Ecobono to sell Bionano's DNA isolation kits to independent clinical laboratories and Chinese hospitals. This could potentially expand Bionano's market reach and increase its revenues. As this is the third such approval for a Bionano OEM partner in China, it indicates a positive trend in regulatory acceptance of Bionano's products in the country.